0000899243-22-028290.txt : 20220810
0000899243-22-028290.hdr.sgml : 20220810
20220810190359
ACCESSION NUMBER: 0000899243-22-028290
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220808
FILED AS OF DATE: 20220810
DATE AS OF CHANGE: 20220810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mahmood Nadir
CENTRAL INDEX KEY: 0001816598
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 221153168
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-582-4923
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-08
0
0001787400
Nkarta, Inc.
NKTX
0001816598
Mahmood Nadir
C/O NKARTA, INC.
6000 SHORELINE COURT, SUITE 102
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
See Remarks
Common Stock
2022-08-08
4
M
0
7500
3.89
A
53588
D
Common Stock
2022-08-08
4
S
0
7500
15.32
D
46088
D
Stock Option (right to buy)
3.89
2022-08-08
4
M
0
7500
0.00
D
2029-09-05
Common Stock
7500
32522
D
The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person at least 30 days prior to the trade date.
This transaction was executed in multiple trades at prices ranging from $15.00 to $15.85. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.
Chief Financial and Business Officer
/s/ Alicia Hager, as Attorney-in-Fact
2022-08-10